Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)


Study Number
42816
Phase
2
Purpose

This study is a prospective, multicenter phase II study with patients receiving haploidentical transplantation for Severe Aplastic Anemia (SAA). The primary objective is to assess overall survival (OS) at 1 year post-hematopoietic stem cell transplantation (HSCT).

Full Title

BMT CTN 1502 Optimizing Haploidentical Aplastic Anemia Transplantation (CHAMP)

ClinicalTrials.Gov ID
NCT02918292

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.